J&J vows appeal after US jury hits it with record $1.5 billion talc cancer award

Core Viewpoint - A Baltimore jury has ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who alleged that long-term exposure to asbestos in the company's talc-based products led to her diagnosis of peritoneal mesothelioma, a type of cancer [1] Group 1 - The jury's decision highlights ongoing legal challenges faced by Johnson & Johnson regarding the safety of its talc-based products [1] - The case underscores the potential health risks associated with asbestos exposure linked to consumer products [1] - This ruling may have significant financial implications for Johnson & Johnson, impacting its overall market position and investor confidence [1]